Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

48.50 

-0.10 -0.2%

as of May 14 '21

52 Week Range:

32.20 48.95


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21
Equity (BVPS) 7.22
7.99
8.94
10.49
11.64
13.66
15.10
22.95
23.81
23.09
26.51
growth rate 10.7% 11.9% 17.3% 11.0% 17.4% 10.5% 52.0% 3.8% -3.0% 14.8%
Earnings BIT 48.53
61.16
106.03
170.39
223.66
265.52
278.66
322.30
300.18
300.36
growth rate 26.0% 73.4% 60.7% 31.3% 18.7% 5.0% 15.7% -6.9% 0.1%
Avg.PE 19.84
23.92
20.24
19.65
31.86
24.62
36.56
4.91
6.03
6.03
growth rate 20.6% -15.4% -2.9% 62.1% -22.7% 48.5% -86.6% 22.8% 0.0%
ROA 3.16
2.64
3.75
4.11
3.51
3.56
2.02
8.85
-0.99
4.09
4.74
growth rate -16.5% 42.1% 9.6% -14.6% 1.4% -43.3% 338.1% -100.0% 100.0% 15.9%
ROE 8.46
9.74
14.89
13.95
13.14
14.56
8.86
33.94
-3.15
12.55
13.02
growth rate 15.1% 52.9% -6.3% -5.8% 10.8% -39.2% 283.1% -100.0% 100.0% 3.8%
ROIC 6.20
5.25
7.91
8.25
6.90
6.72
4.75
13.47
2.08
7.33
7.96
growth rate -15.3% 50.7% 4.3% -16.4% -2.6% -29.3% 183.6% -84.6% 252.4% 8.6%
Cur. Ratio 1.98
2.30
1.70
2.10
2.04
2.33
2.06
2.46
2.37
2.44
2.21
growth rate 16.2% -26.1% 23.5% -2.9% 14.2% -11.6% 19.4% -3.7% 3.0% -9.4%
Quick Ratio 1.06
1.24
0.92
1.10
1.10
1.14
1.10
1.41
1.39
1.64
1.20
growth rate 17.0% -25.8% 19.6% 0.0% 3.6% -3.5% 28.2% -1.4% 18.0% -26.8%
Leverage 2.92
4.36
3.64
3.19
4.25
3.96
4.76
3.19
3.14
3.00
2.52
growth rate 49.3% -16.5% -12.4% 33.2% -6.8% 20.2% -33.0% -1.6% -4.5% -16.0%
Balance Sheet Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21
Acct.Receivable 44.40
65.51
79.40
71.59
87.86
95.25
136.74
140.88
148.79
150.52
growth rate 47.6% 21.2% -9.8% 22.7% 8.4% 43.6% 3.0% 5.6% 1.2%
Acct.Payable 63.92
96.67
84.36
46.12
38.30
70.22
61.39
56.56
62.38
growth rate 51.2% -12.7% -45.3% -17.0% 83.4% -12.6% -7.9% 10.3%
Cur.Assets 107.60
147.04
164.17
177.19
201.71
249.01
334.43
303.48
300.94
365.65
growth rate 36.7% 11.7% 7.9% 13.8% 23.5% 34.3% -9.3% -0.8% 21.5%
Total Assets 1,056.90
1,758.28
1,739.80
1,795.66
2,641.97
2,948.79
3,911.35
3,760.61
3,441.04
3,513.91
growth rate 66.4% -1.1% 3.2% 47.1% 11.6% 32.6% -3.9% -8.5% 2.1%
Cash 13.30
19.02
15.67
28.33
21.32
27.23
41.86
32.55
27.53
94.76
growth rate 43.0% -17.6% 80.8% -24.8% 27.7% 53.7% -22.2% -15.4% 244.2%
Inventory 39.80
51.11
60.20
65.59
74.00
91.26
115.61
118.55
119.88
116.03
growth rate 28.4% 17.8% 9.0% 12.8% 23.3% 26.7% 2.5% 1.1% -3.2%
Cur.Liabilities 54.20
63.92
96.67
84.36
99.04
106.68
162.01
123.20
126.98
149.88
growth rate 17.9% 51.2% -12.7% 17.4% 7.7% 51.9% -24.0% 3.1% 18.0%
Liabilities 695.10
1,355.55
1,261.86
1,232.30
2,014.34
2,204.46
3,088.80
2,582.00
2,345.21
2,342.93
growth rate 95.0% -6.9% -2.3% 63.5% 9.4% 40.1% -16.4% -9.2% -0.1%
LT Debt 486.90
1,123.91
970.90
934.41
1,561.27
1,625.31
2,193.73
1,992.95
1,798.60
1,734.71
growth rate 130.8% -13.6% -3.8% 67.1% 4.1% 35.0% -9.2% -9.8% -3.6%
Equity 361.80
402.73
477.94
563.36
627.62
744.34
822.55
1,178.61
1,095.83
1,170.97
growth rate 11.3% 18.7% 17.9% 11.4% 18.6% 10.5% 43.3% -7.0% 6.9%
Common Shares 50.00
51.00
51.00
52.00
53.00
53.00
53.00
54.00
52.00
51.00
51.00
growth rate 2.0% 0.0% 2.0% 1.9% 0.0% 0.0% 1.9% -3.7% -1.9% 0.0%
Cash Flow Statement Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21
Capital Expenditures 0.60
0.61
10.27
2.76
6.10
3.57
2.98
12.53
10.48
14.56
growth rate 1.0% 1,594.4% -73.1% 120.7% -41.5% -16.6% 321.0% -16.4% 38.9%
Cash Dividends 0.00 0.00 0.00
growth rate
Cash From OA 86.70
67.45
137.61
111.58
156.26
176.31
148.67
210.11
189.28
217.12
growth rate -22.2% 104.0% -18.9% 40.0% 12.8% -15.7% 41.3% -9.9% 14.7%
FCF per Share 1.71
1.43
2.17
2.18
2.49
3.46
3.29
2.83
3.47
3.90
4.08
growth rate -16.4% 51.8% 0.5% 14.2% 39.0% -4.9% -14.0% 22.6% 12.4% 4.6%
Sale Purchase of Stock 0.89
6.03
5.91
4.01
7.23
4.03
1.62
growth rate 578.2% -2.0% -32.1% 80.3% -44.3% -59.8%
FCF 86.00
67.00
127.00
109.00
150.00
171.00
145.00
198.00
179.00
200.00
213.00
growth rate -22.1% 89.6% -14.2% 37.6% 14.0% -15.2% 36.6% -9.6% 11.7% 6.5%
Income Statement Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21
Sales 336.50
441.09
620.12
597.38
714.62
806.25
882.06
1,041.18
975.78
963.01
growth rate 31.1% 40.6% -3.7% 19.6% 12.8% 9.4% 18.0% -6.3% -1.3%
Op.Income 76.10
31.80
64.06
188.62
223.66
265.52
278.66
322.30
300.18
300.36
growth rate -58.2% 101.4% 194.4% 18.6% 18.7% 5.0% 15.7% -6.9% 0.1%
IBT 48.50
61.16
106.03
101.75
127.46
157.19
110.85
107.09
-38.06
191.15
growth rate 26.1% 73.4% -4.0% 25.3% 23.3% -29.5% -3.4% -100.0% 100.0%
Net Income 29.20
31.80
64.06
72.62
78.26
99.91
69.40
339.57
-35.80
142.28
growth rate 8.9% 101.4% 13.4% 7.8% 27.7% -30.5% 389.3% -100.0% 100.0%
EPS 0.58
0.73
1.27
1.39
1.49
1.88
1.30
6.34
-0.69
2.78
3.25
growth rate 25.9% 74.0% 9.5% 7.2% 26.2% -30.9% 387.7% -100.0% 100.0% 16.9%
Gross Profit 170.90
227.38
343.74
335.55
408.42
468.61
503.73
585.20
560.51
565.66
growth rate 33.1% 51.2% -2.4% 21.7% 14.7% 7.5% 16.2% -4.2% 0.9%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 76.40
83.12
80.12
72.90
73.44
growth rate 8.8% -3.6% -9.0% 0.7%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 144.50
150.52
112.32
122.21
116.00
growth rate 4.2% -25.4% 8.8% -5.1%
Acct.Payable 50.41
62.38
32.35
55.42
29.11
growth rate 23.7% -48.1% 71.3% -47.5%
Cur.Assets 300.37
365.65
295.56
269.85
301.21
growth rate 21.7% -19.2% -8.7% 11.6%
Total Assets 3,464.20
3,513.91
3,450.15
3,434.31
3,468.77
growth rate 1.4% -1.8% -0.5% 1.0%
Cash 28.59
94.76
57.94
26.60
62.10
growth rate 231.4% -38.9% -54.1% 133.4%
Inventory 121.36
116.03
116.81
114.03
117.01
growth rate -4.4% 0.7% -2.4% 2.6%
Cur.Liabilities 149.04
149.88
131.93
136.12
126.16
growth rate 0.6% -12.0% 3.2% -7.3%
Liabilities 2,307.71
2,342.93
2,223.13
2,156.09
2,145.55
growth rate 1.5% -5.1% -3.0% -0.5%
LT Debt 1,701.31
1,734.71
1,624.95
1,551.81
1,551.74
growth rate 2.0% -6.3% -4.5% 0.0%
Equity 1,156.49
1,170.97
1,227.01
1,278.22
1,323.22
growth rate 1.3% 4.8% 4.2% 3.5%
Common Shares 50.83
0.54
0.54
0.54
0.54
growth rate -98.9% 0.2% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 3.23
5.51
2.55
9.07
5.73
growth rate 70.3% -53.6% 255.1% -36.8%
Cash Dividends
growth rate
Cash From OA 58.00
56.13
75.15
52.14
49.23
growth rate -3.2% 33.9% -30.6% -5.6%
Sale Purchase of Stock
growth rate
FCF 54.77
50.62
72.60
43.07
43.50
growth rate -7.6% 43.4% -40.7% 1.0%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 215.44
251.24
229.39
237.42
238.79
growth rate 16.6% -8.7% 3.5% 0.6%
Op.Income 76.40
83.12
80.12
72.90
73.44
growth rate 8.8% -3.6% -9.0% 0.7%
IBT 50.55
50.54
58.17
51.90
53.68
growth rate 0.0% 15.1% -10.8% 3.4%
Net Income 38.06
37.05
43.71
44.59
40.87
growth rate -2.7% 18.0% 2.0% -8.3%
EPS
growth rate
Gross Profit 137.50
154.20
135.27
139.18
140.53
growth rate 12.2% -12.3% 2.9% 1.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (66.12)

YOY Growth Grade:

D (48.43)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 6.03 7.61 12.52
EPS / Growth 14.1% 6.37 11.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.3% 12.3% 12.3%
Future PE 6.03 14.36 14.36
Future EPS 18.53 20.27 20.27
Value Price
MOS %
27.62
-43.0%
71.96
48.4%
71.96
48.4%
MOS Price 13.81 35.98 35.98
IRT 5.34 5.22 5.22

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.